Literature DB >> 21057314

Hyperglycemia after pediatric cardiac surgery: impact of age and residual lesions.

Michael-Alice Moga1, Cedric Manlhiot, Eva M Marwali, Brian W McCrindle, Glen S Van Arsdell, Steven M Schwartz.   

Abstract

OBJECTIVE: We evaluated the effect of patient age and significant residual cardiac lesions on the association between hyperglycemia and adverse outcomes in children after cardiac surgery. The incidence, severity, and duration of hyperglycemia in this patient population and perioperative factors predisposing to hyperglycemia were also delineated.
DESIGN: Retrospective, observational cohort study.
SETTING: Eighteen-bed pediatric cardiac critical care unit. PATIENTS: Seven hundred seventy-two children undergoing cardiac surgery with cardiopulmonary bypass during 2006 and 2007.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Postoperative glucose levels were reviewed in all children who underwent cardiac surgery with cardiopulmonary bypass at our institution during 2006 and 2007 who met all inclusion criteria and none of the exclusion criteria (n = 772). The composite morbidity-mortality outcome included hospital death, cardiac arrest, renal/hepatic failure, lactic acidosis, extracorporeal membrane oxygenation use, or infection. Hyperglycemia occurred in 90% of patients and resolved within 72 hrs in most without exogenous insulin. Preoperative factors, including prostaglandins, mechanical ventilation, and cyanosis, were significantly associated with increased odds of significant hyperglycemia (>180 mg/dL for >12 hrs or any level >270 mg/dL) as were increased surgical complexity and perioperative steroid administration. Thirty-one percent of the entire cohort reached the composite outcome and the odds were significantly increased after 54 hrs of mild (elevated, but <180 mg/dL), 12 hrs of moderate (180-270 mg/dL), or any period of severe hyperglycemia (>270 mg/dL). Neonates (<1 month of age) tolerated longer periods of hyperglycemia before showing increased odds of reaching the composite morbidity-mortality end point. In the setting of important residual cardiac lesions, mild or moderate hyperglycemia was not as strongly associated with adverse outcomes.
CONCLUSIONS: Age and residual cardiac lesions are important modifiers of the association between hyperglycemia and suboptimal outcomes after pediatric cardiac surgery. Use of insulin therapy for glucose control in this patient population may need to be carefully targeted toward high-risk subsets of patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21057314     DOI: 10.1097/CCM.0b013e3181fee88e

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Design and rationale of safe pediatric euglycemia after cardiac surgery: a randomized controlled trial of tight glycemic control after pediatric cardiac surgery.

Authors:  Michael G Gaies; Monica Langer; Jamin Alexander; Garry M Steil; Janice Ware; David Wypij; Peter C Laussen; Jane W Newburger; Caren S Goldberg; Frank A Pigula; Avinash C Shukla; Christopher P Duggan; Michael S D Agus
Journal:  Pediatr Crit Care Med       Date:  2013-02       Impact factor: 3.624

Review 2.  Endocrinologic Diseases in Pediatric Cardiac Intensive Care.

Authors:  Carmen L Soto-Rivera; Steven M Schwartz; Jaclyn E Sawyer; Duncan J Macrae; Michael S D Agus
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

3.  Validation of the Glycemic Stress Index in Pediatric Neurosurgical Intensive Care.

Authors:  Marco Piastra; Alessandro Pizza; Federica Tosi; Sonia Mensi; Luca Massimi; Andrea De Bellis; Daniele G Biasucci; Ersilia Luca; Giorgio Conti; Daniele De Luca
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

4.  Glycemic control in pediatric patients on extracorporeal membrane oxygenation.

Authors:  Kathryn L Wierer; Rachel A Pagryzinski; Qun Xiang
Journal:  J Pediatr Pharmacol Ther       Date:  2013-07

Review 5.  Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.

Authors:  Allan Doctor; Jerry Zimmerman; Michael Agus; Surender Rajasekaran; Juliane Bubeck Wardenburg; James Fortenberry; Anne Zajicek; Emma Mairson; Katri Typpo
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

6.  Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trial.

Authors:  Michael S D Agus; Lisa A Asaro; Garry M Steil; Jamin L Alexander; Melanie Silverman; David Wypij; Michael G Gaies
Journal:  Circulation       Date:  2014-03-26       Impact factor: 29.690

7.  Postoperative outcome for hyperglycemic pediatric cardiac surgery patients.

Authors:  Fariba Alaei; Paridokht Nakhostin Davari; Mastaneh Alaei; Rasoul Azarfarin; Ebrahim Soleymani
Journal:  Pediatr Cardiol       Date:  2011-08-18       Impact factor: 1.655

8.  A composite outcome for neonatal cardiac surgery research.

Authors:  Ryan J Butts; Mark A Scheurer; Sinai C Zyblewski; Amy E Wahlquist; Paul J Nietert; Scott M Bradley; Andrew M Atz; Eric M Graham
Journal:  J Thorac Cardiovasc Surg       Date:  2013-04-12       Impact factor: 5.209

9.  Predictors of severe postoperative hyperglycemia after cardiac surgery in infants: a single-center, retrospective, observational study.

Authors:  Natsuhiro Yamamoto; Tomoya Irie; Shunsuke Takaki; Osamu Yamaguchi; Takahisa Goto
Journal:  J Anesth       Date:  2018-01-12       Impact factor: 2.078

10.  Tight glycemic control versus standard care after pediatric cardiac surgery.

Authors:  Michael S D Agus; Garry M Steil; David Wypij; John M Costello; Peter C Laussen; Monica Langer; Jamin L Alexander; Lisa A Scoppettuolo; Frank A Pigula; John R Charpie; Richard G Ohye; Michael G Gaies
Journal:  N Engl J Med       Date:  2012-09-07       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.